Tomorrow Health, a NYC-based patient-first platform for home healthcare, closed a $25m Series A funding round.
The round was led by Andreessen Horowitz with participation from Obvious Ventures and BoxGroup. Julie Yoo, General Partner at Andreessen Horowitz, is joining the company’s board.
The company will use the capital to hire additional talent and expand its infrastructure technology to connect every patient with home-based care.
Led by Vijay Kedar, co-founder and Chief Executive Officer, Tomorrow Health provides a platform for home healthcare that enables patients to get the equipment and supplies they require in a streamlined manner. Partnering with payors, referring providers, and DME suppliers, the company provides a data-driven intelligence platform to match patients with high-quality DME suppliers based on insurance coverage, service quality, geography, and product specialization.
Since its public launch in April 2020, Tomorrow Health has partnered with more than 125 health plans and hospital systems.
In addition, the company announced Paul Mango, former Deputy Chief of Staff for Policy at HHS and Roy Beveridge, former Chief Medical Officer at Humana, have joined its Advisory Board.